Respironics to Acquire Healthdyne

Respironics Inc. said it agreed to acquire Healthdyne Technologies Inc. for about $337 million in a stock transaction. The deal would include the assumption of $33 million in Healthdyne debt. Respironics, which is based in Pittsburgh, also said it will take between $25 million and $30 million in related charges in the first quarter of next year, when it expects to close the deal. Healthdyne, based in Marietta, Ga., makes monitoring devices for newborns and products for respiratory disorders. Respironics makes products to detect and treat obstructive sleep apnea, the temporary stopping of breathing. Under the definitive agreement approved by the boards of both companies, Respironics would exchange $24 worth of its stock for each Healthdyne share, which would amount to $337 million, according to the announcement. Healthdyne’s stock dipped 13 cents to close at $19.75; Respironics shares fell 38 cents to close at $26.25. Both trade on Nasdaq.